# Dana–Farber Cancer Institute

> hospital in Massachusetts, United States

**Wikidata**: [Q1159198](https://www.wikidata.org/wiki/Q1159198)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Dana–Farber_Cancer_Institute)  
**Source**: https://4ort.xyz/entity/danafarber-cancer-institute

## Summary
Dana–Farber Cancer Institute is a research-focused hospital in Boston, Massachusetts, United States, affiliated with Harvard Medical School. Founded in 1947, it is a leading center for cancer research and treatment, recognized as an NCI-designated Cancer Center and a nonprofit organization.

## Key Facts
- **Founded**: 1947
- **Location**: Boston, Massachusetts, United States
- **Affiliation**: Harvard Medical School
- **Classification**: Research institute, NCI-designated Cancer Center, nonprofit organization
- **Legal Form**: 501(c)(3) organization
- **Revenue (2023)**: $3,387,587,769 USD
- **Donations (2023)**: $757,911,838 USD
- **Total Assets (2023)**: $4,735,245,065 USD
- **Named After**: Sidney Farber and the Dana Foundation
- **Key Researchers**: Michael I. Love, Amanda Randles, James P. Bagrow

## FAQs
### Q: What is Dana–Farber Cancer Institute known for?
A: Dana–Farber Cancer Institute is known for its advanced cancer research and treatment, particularly in pediatric oncology, immunotherapy, and clinical trials. It is one of the largest cancer centers in the U.S. and is affiliated with Harvard Medical School.

### Q: Where is Dana–Farber Cancer Institute located?
A: The institute is located in Boston, Massachusetts, United States, with its headquarters in Boston.

### Q: Who founded Dana–Farber Cancer Institute?
A: The institute was founded in 1947 and is named after Sidney Farber and the Dana Foundation.

### Q: What types of cancer research does Dana–Farber conduct?
A: Dana–Farber conducts research in various areas, including pediatric oncology, immunotherapy, and clinical trials, making significant contributions to cancer treatment and prevention.

### Q: How can I donate to Dana–Farber Cancer Institute?
A: Donations can be made through the institute's official website, and the amount varies by year, with $757,911,838 USD received in 2023.

## Why It Matters
Dana–Farber Cancer Institute plays a crucial role in advancing cancer research and treatment. As an NCI-designated Cancer Center, it conducts groundbreaking research that has led to innovative therapies and improved patient outcomes. The institute is particularly renowned for its work in pediatric oncology and immunotherapy, making it a leader in the field. By collaborating with Harvard Medical School, Dana–Farber fosters a culture of innovation and excellence, contributing significantly to global cancer research efforts. Its nonprofit status ensures that resources are dedicated solely to advancing cancer care without commercial influence.

## Notable For
- **NCI-Designated Cancer Center**: Recognized by the National Cancer Institute for its excellence in cancer research.
- **Pediatric Oncology Leadership**: Pioneering research in pediatric cancer treatments.
- **Harvard Affiliation**: Strong academic partnership with Harvard Medical School, enhancing research capabilities.
- **Clinical Trials**: Conducts numerous clinical trials, contributing to advancements in cancer treatment.
- **Nonprofit Status**: Operates as a 501(c)(3) organization, ensuring all funds go toward cancer research and patient care.

## Body
### Overview
Dana–Farber Cancer Institute is a leading research-focused hospital in Boston, Massachusetts, established in 1947. It is affiliated with Harvard Medical School and is recognized as an NCI-designated Cancer Center, indicating its status as a premier institution for cancer research and treatment.

### Research and Treatment
The institute is renowned for its contributions to pediatric oncology, immunotherapy, and clinical trials. It conducts groundbreaking research that has led to innovative therapies and improved patient outcomes. Dana–Farber is particularly known for its work in pediatric cancer, making significant strides in the treatment of childhood cancers.

### Financials and Operations
- **Revenue**: The institute's revenue has shown steady growth, reaching $3,387,587,769 USD in 2023.
- **Donations**: Donations totaled $757,911,838 USD in 2023, reflecting strong public support.
- **Total Assets**: Total assets were $4,735,245,065 USD in 2023, indicating substantial financial resources dedicated to cancer research.

### Affiliations and Recognition
- **Harvard Medical School**: The institute's affiliation with Harvard Medical School enhances its research capabilities and academic collaborations.
- **NCI Designation**: As an NCI-designated Cancer Center, Dana–Farber is recognized for its excellence in cancer research and treatment.
- **Nonprofit Status**: Operating as a 501(c)(3) organization, Dana–Farber ensures that all funds are dedicated to cancer research and patient care.

### Key Researchers
- **Michael I. Love**: A biostatistician and computer scientist who has contributed to cancer research.
- **Amanda Randles**: An American computer scientist and engineer known for her research in cancer treatment.
- **James P. Bagrow**: A researcher and physicist who has made significant contributions to cancer research.

### Social Media Presence
- **Twitter**: The institute has a verified Twitter account (@DanaFarber) with over 110,000 followers as of 2023.
- **YouTube**: Dana–Farber has a YouTube channel with over 52,700 subscribers, providing educational content on cancer research and treatment.

### Historical Context
- **Founding**: Established in 1947, the institute was named after Sidney Farber and the Dana Foundation, reflecting its origins in community-driven cancer care.
- **Milestones**: Over the years, Dana–Farber has achieved numerous milestones, including groundbreaking research in pediatric oncology and immunotherapy.

### Impact and Legacy
Dana–Farber Cancer Institute has made significant contributions to cancer research and treatment, particularly in pediatric oncology and immunotherapy. Its work has led to innovative therapies and improved patient outcomes, solidifying its reputation as a leader in the field. The institute's nonprofit status and affiliation with Harvard Medical School ensure that it remains a beacon of excellence in cancer care.

## References

1. [Source](https://www.dana-farber.org/about-us/history-and-milestones/)
2. A tribute to Sidney Farber-- the father of modern chemotherapy
3. [Source](https://www.charitynavigator.org/ein/042263040)
4. GRID Release 2017-01-10
5. Virtual International Authority File
6. BnF authorities
7. [Source](https://www.cogr.edu/cogr-membership-list)
8. Freebase Data Dumps. 2013
9. Czech National Authority Database
10. GeoNames
11. [Source](https://www.dana-farber.org/)
12. Nonprofit Explorer
13. [Nonprofit Explorer](https://projects.propublica.org/nonprofits/organizations/42263040)
14. GRID Release 2015-12-14
15. Aligned ISNI and Ringgold identifiers for institutions
16. [Source](https://www.charitynavigator.org/index.cfm?bay=search.alpha&ltr=D#ltr-D)
17. [Source](https://www.charitynavigator.org/index.cfm?bay=search.summary&orgid=3597&oldpage)
18. YouTube API